2Martínez M A,Cabana M,Parera M,et al. A bacteriophage lambda-based genetic screen for characterization of the activity and phenotype of the human immunodeficiency virus type 1 protease[J]. Antimicrobial Agents and Chemotherapy,2000,44:1132-1139.
3Iga M,Matsuda Z,Okayama A,et al. In vitro human immunodeficiency virus type 1protease phenotypic assay using in vitro transcription translation system[C]. In First HIV DRP Symposium Understanding Antiviral Drug Resistance,Chantilly,VA. USA. 2000,40.
4Graham N,Peeters M,Verbiest W,et al. The virtual phenotype is an independent predictor of clinical response[C]. Program and abstracts of the 8th Conferenec on Retroviruses and Opportunistic Infections, Chicago,I11inois. 2001,524.
5Larder BA,Kemp S,Hertogs K. Quantitative prediction of HIV-1 phenotypic drug resistance from genotypes:the virtual phenotype[C]. Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy,Toronto,Ontario,Canada. 200
6Hirsch M S,Brun-Vézinet F,D'Aquila R T,et al. Antiretroviral drug resistance testing in adult HIV-1 infection:recommendations of an international AIDSsociety-USA panel[J]. Journal of the American Medical Association,2000,283:2417-2426.
7Stuyver L,Wyseur A,Rombout A,et al. line probe assay for rapid detection of drug-selected mutationsin the human immunodeficiency virus type 1 reverse transcriptase gene [J]. Antimicrob Agents Chemother,1997,41:284-291.
8Edelstein RE, Nickerson DA, Tobe VO. Oligonucleotide Ligation Assay for Detecting Mutations in the Human Immunodeficiency Virus Type 1 pol Gene That Are Associated with Resistance to Zidovudine,Didanosine,and Lamivudine [J]. Journal of Clinical Microbiolo
9Gunthard HF,Wong JK,Ignacio CC,et al. Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIVtype 1 pol from clinical samples[J]. AIDS Res Hum Retroviruses,1998,14:869-876.
10Kozal MJ,Yahi N,Ariasi F,et al. Comparison of Human immunodeficiency virus type 1 protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy[J]. J Clin Microbiol,1993,3
2Pauwels R, Hertogs K,Kemp S, et al. 2nd International Workshop on HIV Drug Resistance and Treatment Strategies, Lake Maggiore, Italy,1998;Abstr,51
3Deeks SG, Parkin N, Petropoulos CJ, et al. 2nd International Workshop on HIV Drug Resistance and Treatment Strategies, Lake Maggiore, Italy,1998;Abstr,53
9Schmit JC, Ruiz,L,Clotet B, et al. AIDS,1996;10:995-999
10Harrigan PR,Montaner JS, Hogg RS, et al. 2nd International Workshop on HIV Drug Resistance and Treatment Strategies, Lake Maggiore, Italy,1998;Abstr,55
